Global Pet Parasite Prevention and Control Market Research Report 2023

Publication ID:

PB501232705

Publication Date:

January 12, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Pet Parasite Prevention and Control market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pet Parasite Prevention and Control is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pet Parasite Prevention and Control is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pet Parasite Prevention and Control include Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac and Vetoquinol, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Parasite Prevention and Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Parasite Prevention and Control.
The Pet Parasite Prevention and Control market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Parasite Prevention and Control market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Parasite Prevention and Control manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
Segment by Type
Topical Medication
Injection Medication
Oral Medication
Segment by Application
Dog
Cat
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Parasite Prevention and Control manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Parasite Prevention and Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pet Parasite Prevention and Control Market Overview
1.1 Product Overview and Scope of Pet Parasite Prevention and Control
1.2 Pet Parasite Prevention and Control Segment by Type
1.2.1 Global Pet Parasite Prevention and Control Market Value Comparison by Type (2023-2029)
1.2.2 Topical Medication
1.2.3 Injection Medication
1.2.4 Oral Medication
1.3 Pet Parasite Prevention and Control Segment by Application
1.3.1 Global Pet Parasite Prevention and Control Market Value by Application: (2023-2029)
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Global Pet Parasite Prevention and Control Market Size Estimates and Forecasts
1.4.1 Global Pet Parasite Prevention and Control Revenue 2018-2029
1.4.2 Global Pet Parasite Prevention and Control Sales 2018-2029
1.4.3 Global Pet Parasite Prevention and Control Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pet Parasite Prevention and Control Market Competition by Manufacturers
2.1 Global Pet Parasite Prevention and Control Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pet Parasite Prevention and Control Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pet Parasite Prevention and Control Average Price by Manufacturers (2018-2023)
2.4 Global Pet Parasite Prevention and Control Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pet Parasite Prevention and Control, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Parasite Prevention and Control, Product Type & Application
2.7 Pet Parasite Prevention and Control Market Competitive Situation and Trends
2.7.1 Pet Parasite Prevention and Control Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Parasite Prevention and Control Players Market Share by Revenue
2.7.3 Global Pet Parasite Prevention and Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Parasite Prevention and Control Retrospective Market Scenario by Region
3.1 Global Pet Parasite Prevention and Control Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pet Parasite Prevention and Control Global Pet Parasite Prevention and Control Sales by Region: 2018-2029
3.2.1 Global Pet Parasite Prevention and Control Sales by Region: 2018-2023
3.2.2 Global Pet Parasite Prevention and Control Sales by Region: 2024-2029
3.3 Global Pet Parasite Prevention and Control Global Pet Parasite Prevention and Control Revenue by Region: 2018-2029
3.3.1 Global Pet Parasite Prevention and Control Revenue by Region: 2018-2023
3.3.2 Global Pet Parasite Prevention and Control Revenue by Region: 2024-2029
3.4 North America Pet Parasite Prevention and Control Market Facts & Figures by Country
3.4.1 North America Pet Parasite Prevention and Control Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pet Parasite Prevention and Control Sales by Country (2018-2029)
3.4.3 North America Pet Parasite Prevention and Control Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Parasite Prevention and Control Market Facts & Figures by Country
3.5.1 Europe Pet Parasite Prevention and Control Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pet Parasite Prevention and Control Sales by Country (2018-2029)
3.5.3 Europe Pet Parasite Prevention and Control Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Parasite Prevention and Control Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Parasite Prevention and Control Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pet Parasite Prevention and Control Sales by Country (2018-2029)
3.6.3 Asia Pacific Pet Parasite Prevention and Control Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet Parasite Prevention and Control Market Facts & Figures by Country
3.7.1 Latin America Pet Parasite Prevention and Control Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pet Parasite Prevention and Control Sales by Country (2018-2029)
3.7.3 Latin America Pet Parasite Prevention and Control Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Parasite Prevention and Control Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Parasite Prevention and Control Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pet Parasite Prevention and Control Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pet Parasite Prevention and Control Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Parasite Prevention and Control Sales by Type (2018-2029)
4.1.1 Global Pet Parasite Prevention and Control Sales by Type (2018-2023)
4.1.2 Global Pet Parasite Prevention and Control Sales by Type (2024-2029)
4.1.3 Global Pet Parasite Prevention and Control Sales Market Share by Type (2018-2029)
4.2 Global Pet Parasite Prevention and Control Revenue by Type (2018-2029)
4.2.1 Global Pet Parasite Prevention and Control Revenue by Type (2018-2023)
4.2.2 Global Pet Parasite Prevention and Control Revenue by Type (2024-2029)
4.2.3 Global Pet Parasite Prevention and Control Revenue Market Share by Type (2018-2029)
4.3 Global Pet Parasite Prevention and Control Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pet Parasite Prevention and Control Sales by Application (2018-2029)
5.1.1 Global Pet Parasite Prevention and Control Sales by Application (2018-2023)
5.1.2 Global Pet Parasite Prevention and Control Sales by Application (2024-2029)
5.1.3 Global Pet Parasite Prevention and Control Sales Market Share by Application (2018-2029)
5.2 Global Pet Parasite Prevention and Control Revenue by Application (2018-2029)
5.2.1 Global Pet Parasite Prevention and Control Revenue by Application (2018-2023)
5.2.2 Global Pet Parasite Prevention and Control Revenue by Application (2024-2029)
5.2.3 Global Pet Parasite Prevention and Control Revenue Market Share by Application (2018-2029)
5.3 Global Pet Parasite Prevention and Control Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boehringer Ingelheim Pet Parasite Prevention and Control Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Pet Parasite Prevention and Control Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zoetis Pet Parasite Prevention and Control Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Corporation Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dechra Pharmaceuticals Pet Parasite Prevention and Control Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Chanelle Pharma
6.5.1 Chanelle Pharma Corporation Information
6.5.2 Chanelle Pharma Description and Business Overview
6.5.3 Chanelle Pharma Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Chanelle Pharma Pet Parasite Prevention and Control Product Portfolio
6.5.5 Chanelle Pharma Recent Developments/Updates
6.6 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck Animal Health Pet Parasite Prevention and Control Product Portfolio
6.6.5 Merck Animal Health Recent Developments/Updates
6.7 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Pet Parasite Prevention and Control Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Corporation Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Virbac Pet Parasite Prevention and Control Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Vetoquinol
6.9.1 Vetoquinol Corporation Information
6.9.2 Vetoquinol Description and Business Overview
6.9.3 Vetoquinol Pet Parasite Prevention and Control Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Vetoquinol Pet Parasite Prevention and Control Product Portfolio
6.9.5 Vetoquinol Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Parasite Prevention and Control Industry Chain Analysis
7.2 Pet Parasite Prevention and Control Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Parasite Prevention and Control Production Mode & Process
7.4 Pet Parasite Prevention and Control Sales and Marketing
7.4.1 Pet Parasite Prevention and Control Sales Channels
7.4.2 Pet Parasite Prevention and Control Distributors
7.5 Pet Parasite Prevention and Control Customers
8 Pet Parasite Prevention and Control Market Dynamics
8.1 Pet Parasite Prevention and Control Industry Trends
8.2 Pet Parasite Prevention and Control Market Drivers
8.3 Pet Parasite Prevention and Control Market Challenges
8.4 Pet Parasite Prevention and Control Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂